SubscribeLogin
Cardiovascular News image

News from Cardiovascular News

We’ve assigned a rating of Unknown factuality to Cardiovascular News. You can read more about how we’ve determined Cardiovascular News’s credibility and reliability as a news source here: https://ground.news/rating-system.

Information about Cardiovascular News

Where is Cardiovascular News located?Cardiovascular News's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Cardiovascular News News

DCB is an effective option for PCI in patients with diabetes - Cardiovascular News
Diabetes · São Paulo

DCB is an effective option for PCI in patients with diabetes - Cardiovascular News

Diabetes is one of the strongest risk factors for coronary disease, Pedro Lemos (Hospital Israelita Albert Einstein, São Paulo, Brazil) tells Cardiovascular News, discussing his strategies for managing the treatment of diabetic patients in the cath lab. In this interview, he explains why using a drug-coated balloon (DCB) may be an appealing option when it comes to the treatment of coronary artery disease, particularly among a subset of patients …See the Story
First-in-human results “demonstrate potential of Reprieve system” in ADHF treatment - Cardiovascular News
Frankfurt · Frankfurt

First-in-human results “demonstrate potential of Reprieve system” in ADHF treatment - Cardiovascular News

Reprieve Cardiovascular has announced the first-in-human results of the Reprieve System at the CSI Focus D-HF—device therapies in heart failure—conference (13–14 December, Frankfurt, Germany). Results of the study demonstrated the potential of the Reprieve system to safely accelerate and maximise decongestion while reducing the likelihood of kidney injury for patients with ADHF. “Heart failure patients with fluid volume overload are particularly…See the Story
First phase of BiVACOR early feasibility study completed - Cardiovascular News
FDA · Houston

First phase of BiVACOR early feasibility study completed - Cardiovascular News

BiVACOR has announced the successful completion of the first phase of the US Food and Drug Administration (FDA) early feasibility study, with five patients receiving the BiVACOR total artificial heart (TAH) between July and November 2024. The study evaluates the safety and performance of the BiVACOR TAH system in patients as a bridge to donor heart transplant. This study assessed the feasibility of using the BiVACOR TAH system to support adult p…See the Story

Latest News Stories

You've scrolled to the bottom of the feed, there are no more stories.
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal